| Nov 13 |
Equillium GAAP EPS of $0.00 misses by $0.02, revenue of $12.16M beats by $0.61M
|
| Nov 13 |
Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
|
| Nov 13 |
Equillium to Present at the Stifel Healthcare Conference
|
| Nov 12 |
Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
|
| Nov 6 |
Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth
|
| Oct 31 |
Equillium says Ono not acquiring itolizumab, stock craters 36%
|
| Oct 31 |
Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates
|
| Oct 31 |
Equillium Maintains Rights to Itolizumab Following Ono Partnership
|
| Oct 31 |
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
| Oct 22 |
Alto Ingredients And 2 Other US Penny Stocks To Watch Closely
|
